Table 2 Linear regression analysis results of clinical markers of trigeminal activation
From: Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal
Beta | 95% CI | P-value | |
|---|---|---|---|
Unilateral autonomic symptoms | 2.07 | −7.53 - 11.68 | 0.670 |
Conjunctival injection and/or lacrimation | −4.27 | −21.90 - 13.37 | 0.633 |
Nasal congestion and/or rhinorrhea | −8.69 | −36.22 - 18.85 | 0.534 |
Eyelid edema | −14.57 | −34.06 - 4.92 | 0.141 |
Ptosis | −1.39 | −9.76 - 6.98 | 0.743 |
Any | −2.87 | −9.93 - 4.19 | 0.422 |
Headache unilaterality | 2.07 | −7.53 - 11.68 | 0.670 |